Navigation Links
BioDrain Announces First Quarter 2013 Results
Date:5/15/2013

MINNEAPOLIS, May 15, 2013 /PRNewswire/ -- BioDrain Medical, Inc. (OTCQB: BIOR) (the "Company"), producer of the FDA approved STREAMWAY System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, today reported its results for the first quarter ended March 31, 2013.

Key Highlights:

  • Revenues of $127,727 for Q1 2013 were up over 450% compared to Q1 2012
  • Sales to operating rooms, surgical centers and hospital systems in new geographies have expanded BioDrain's presence in the surgical waste fluid management industry
  • Purchase order and trial unit for the first quarter exceed 20 STREAMWAY Systems
  • Revenues for the first quarter of 2013 were $127,727, up over 450% compared to $22,635 for the same period in 2012. Gross profit for the first quarter of 2013 was $86,123, nearly a 10-fold increase from $8,829 for the same period in 2012.

    Net loss for the period was ($2.1) million, or ($0.02) per diluted share, compared to net loss of ($713,367), or ($0.02) per diluted share, in the comparable period in 2012. The increased loss resulted in part from increased stock compensation costs due to stock option valuations for the first quarter, as well as an increase in investor stock compensation, a method of remuneration to an investor in lieu of cash equity financing raised as the Company ramps up production to meet second and third quarter demand. BioDrain CEO, Josh Kornberg , emphasized, "We have proposed additional small financing to allow us to further our production capability to meet market demand."

    Mr. Kornberg continued, "BioDrain had a great first quarter in 2013. Not only do we have a robust new business pipeline that includes numerous hospital networks and surgical centers, but in the past several weeks we have added new installations and ex
    '/>"/>

    SOURCE BioDrain Medical, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. BioDrain Medical Exhibits at National Registered Nurses Conference
    2. BioDrain Medical Retains KCSA Strategic Communications as Corporate Communications Counsel
    3. BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence
    4. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
    5. International Isotopes Inc. Announces First Quarter 2013 Financial Results
    6. Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
    7. Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement
    8. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
    9. Heska Announces Financial Results for the First Quarter of Fiscal 2013
    10. DEACOM ERP Announces MRO Module for Process and Mixed Mode Manufacturing Companies
    11. Natural Alternatives International, Inc. Announces Fiscal 2013 Q3 and YTD Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... 22, 2014 Antigen Discovery Inc. (ADi), a ... , announced the receipt of a National Institutes of ... from the National Institute of Dental and Craniofacial Research (NIDCR). ... a Pan-HIV Protein Microarray Chip, which will contain every ... and aid in the development of safe and effective ...
    (Date:10/22/2014)... 22, 2014   Reproductive Medicine Associates of ... the field of infertility, presents new clinical research ... The research abstract, released during the 70 th ... meeting in Honolulu, Hawaii , ... defect (SGD) pre-implantation genetic diagnosis (PGD). ...
    (Date:10/22/2014)... Oct. 22, 2014  Paper Pak Industries, a ... APLS ® Body Guard Bio, a disposable, ... of bacteria and virus while protecting service providers ... Bio features a rugged, external nylon shell, watertight ... a leak-proof inner chamber that contains contaminated and ...
    Breaking Medicine Technology:Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
    ... New Studies Highlight Potential Benefit of Unique ... -- Stimulant drug abuse,remains an ongoing concern ... treat Attention Deficit Hyperactivity Disorder,(ADHD). Data presented ... of,the American Psychiatric Association highlighted findings that,long-acting ...
    ... Austria, May 23, 2007-The chemotherapy drug,docetaxel currently offers ... the result of a now,published clinical trial that ... chemotherapy drugs. When using docetaxel, the risk of,disease ... when using the,next-best chemotherapy drug. , The use ...
    Cached Medicine Technology:New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 2New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 3New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 4New Data Suggests Less Abuse-Related Effects For OROS,Methylphenidate 5Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 2Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 3
    (Date:10/22/2014)... Los Angeles, California (PRWEB) October 22, 2014 ... Recovery 2.0: Move Beyond Addiction and Upgrade Your Life (Paperback; ... the field of Yoga & Recovery. This book is ... and thrive in a life of recovery. , Recovery ... of the 12 Steps; Recovery 2.0 is a guide for ...
    (Date:10/22/2014)... Best Cheap Hosting USA is among ... site has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) ... from around the world. , “iPower is one of ... is providing various kinds of useful products for new ... offering excellent customer service and a number of features ...
    (Date:10/22/2014)... Although there are only 24 hours in a day, ... have trouble finding time within their busy schedules for exercise and ... of time to get in shape. Here are five ways you ... , Change Up Your Commute , Consider riding a bike ... exercise into your daily routine. If you must use your car ...
    (Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
    (Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
    Breaking Medicine News(10 mins):Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
    ... risk of post-traumatic stress, study finds, , , THURSDAY, ... children in pediatric intensive care units experience delusions, and ... of developing post-traumatic stress syndrome after their hospital stay. ... to be sedated for more than two days, and ...
    ... Palomid 529 as an inhibitor of macular degeneration, diabetic ... ... Mass., May 1 Paloma Pharmaceuticals,Inc. today announced it has ... for Research in Vision and Ophthalmology (ARVO),describing the activity of ...
    ... CONSHOHOCKEN, Pa., May 1 Cadient Group, the,premier ... today it has appointed Barbara Dowling as Senior ... the healthcare,vertical on both the client and agency ... digital channel to address business critical,issues. In this ...
    ... 1 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ... 2008 results conference call and Annual Meeting of Shareholders., ... May 8 at 8:30 a.m. (ET) Labopharm will host ... results. Labopharm will,report its first quarter 2008 financial results ...
    ... N.Y., May 1 Gentiva Health,Services, Inc. (Nasdaq: GTIV ... reported the following financial,results for the first quarter ended March ... ), -- Net revenues increased 8% to $323.7 million ... 1, 2007. -- Net income increased 13% to $7.7 ...
    ... three children admitted to pediatric intensive care will experience ... for post-traumatic stress symptoms, according to a new study ... (PICU). , The study, which appears in the ... Respiratory and Critical Care Medicine, published by the American ...
    Cached Medicine News:Health News:Delusions Common in Pediatric ICU 2Health News:Delusions Common in Pediatric ICU 3Health News:Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting 2Health News:Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting 3Health News:Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting 4Health News:Cadient Group Appoints Barbara Dowling to Senior Vice President Customer Engagements 2Health News:Labopharm announces details for first quarter results conference call and annual meeting 2Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 2Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 3Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 4Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 5Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 6Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 7Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 8Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 9Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 10Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 11Health News:Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook 12Health News:Haunted by hallucinations: Children in the PICU traumatized by delusions 2
    ... Avaulta™ BioSynthetic Mesh is ... coated in the central ... hydrophilic film of porcine ... of the Avaulta™ BioSynthetic ...
    Comprised of a monofilament polypropylene mesh coated with hydrophilic porcine collagen, Pelvitex™ mesh is clinically proven coating to enhance the healing process, along with the strength and d...
    ... is a soft monofilament ... be used for a ... procedures, including cystocele, rectocele, ... yet strong, POPmeshs flexibility ...
    ... Hydrix XM is a ... pericardium, a material known for ... sourcing and manufacturing procedures ensure ... safety. Caldera's patented processing enhances ...
    Medicine Products: